Aesthetics

Pharmaceutical Specialties is demonstrating its Vanicream Sunscreens at the 63rd Annual Meeting here.

Silicone sheet technology has been clinically proven to improve the appearance of scars significantly and has been used by physicians for years, according to Pfizer who is displaying its Neosporin Scar Sheets here at the 63rd Annual Meeting.

Del Pharmaceuticals is displaying its newest product, Dermarest Stretch Mark Repair Cream, at the 63rd Annual Meeting.

Allergan, Inc., has launched Prevage, antioxidant cream, the first and only clinically tested antioxidant that not only reduces the appearance of fine lines and wrinkles, but also provides protection against environmental factors including sun damage, air pollution and cigarette smoke, says the company.

Dermatologists should become environmental activists in their communities and on a broader scale, urges Peyton E. Weary, M.D.

Former AAD president, Rex A. Amonette, M.D., received the Gold Metal award, the highest award given by the Academy, yesterday.

Members of the American Academy of Dermatology and the AAD Association began voting online Sunday for 2006 officers and directors.

The Women's Dermatologic Society celebrated its thirtieth year in existence in an awards luncheon yesterday.

Clay J. Cockerell, M.D., assumes the post of AAD president tomorrow.

Neocutis, San Francisco, is introducing Bio-restorative Skin Cream with PSP. PSP is a proprietary cosmetic ingredient developed at the University of Lausanne, Switzerland. It is the only cosmeceutical product containing the specific natural human growth factors, cytokines and enzymatic antioxidants associated with natural bio-restoration of the skin to promote scarless wound healing. According to the company, the unique formulation of PSP provides skin with the optimal balance of skin nutrients helping to preserve or restore skin when stressed.

Neocutis, San Francisco, is introducing Bio-restorative Skin Cream with PSP. PSP is a proprietary cosmetic ingredient developed at the University of Lausanne, Switzerland. It is the only cosmeceutical product containing the specific natural human growth factors, cytokines and enzymatic antioxidants associated with natural bio-restoration of the skin to promote scarless wound healing. According to the company, the unique formulation of PSP provides skin with the optimal balance of skin nutrients helping to preserve or restore skin when stressed.

Valeant Pharmaceuticals is displaying two new products in its Kinerase line.

PharmaDerm is launching two new marketing campaigns toward dermatologists at the 63rd Annual Meeting.

WaveLight Laser Technolgie AG of Erlangen, Germany, is introducing three aesthetic lasers to the U.S. market at the 63rd Annual Meeting. Already used in Europe and Asia, the Sinon Q-switched ruby, the Mydon Nd:YAG and the Arion Alexandrite lasers will be Wavelight's first products to enter the U.S. market.

According to a research study presented yesterday, infliximab (Remicade) was found effective in treating psoriatic arthritis.

Botulinum toxin type A (Botox Cosmetic, Allergan) can be used safely and effectively in a range of doses to simultaneously treat a spectrum of upper facial rhytids in adult women, but a higher dose provides more marked and more durable efficacy without compromising safety, according to the results of a dose-comparison study presented by Alastair Carruthers, M.D., and Jean Carruthers, M.D.

Boni E. Elewski, M.D., president of the American Academy of Dermatology (AAD), will award the distinguished presidential citation to 20 members today.

Familiarity with popular beliefs about factors affecting acne is an integral part of managing patients.

Botulinum toxin treatments in the lower third of the face and the neck require caution.

While psychological stress impacts skin function, its effects on human skin physiology have not been well documented.

Psoriasis is a chronic skin disorder that affects approximately 2 percent of the U.S. and European population.

While psychological stress impacts skin function, its effects on human skin physiology have not been well documented.

As researchers learn more about botulinum toxin, clinicians continue to refine techniques for treating the upper face, especially in male patients.

Botulinum toxin treatments in the lower third of the face and the neck require caution.

Hand eczema is one of the most common work-related illnesses or diseases, but diagnosis is complicated.